RMAX

RMAX is a 100%-franchised, capital-light brand licensor (RE/MAX real estate + Motto mortgage) that, per the MD&A, runs a 'low fixed-cost structure' with 'recurring fee-based models' that yield high margins and cash flow. The margin math bears this out: operating income grew +17.1% to $47.0M (16.1% operating margin) and net income rose +14.5% to $8.15M even as revenue fell -5.2% to $292M. That is quality cost discipline — but it is profit growth manufactured on a shrinking top line. Revenue has now declined for four of the last four years off the FY2022 peak ($353M → $326M → $308M → $292M), and operating cash flow dropped -31.5% to $40.9M. The improving bottom line is real, but it is not the same as a healthy, growing business.

The filing tells you why the top line keeps sliding and flags a structural risk hiding inside the 'stabilization' narrative. Management touts a record 148,500 global agents and 'three consecutive quarters of stabilization' in U.S. agent count, but concedes macro headwinds 'contributed to declines in U.S. RE/MAX agent count, open Motto offices, and total revenue.' Meanwhile the new economic models are a double-edged sword: Aspire, Ascend and Appreciate are explicitly designed to cut fixed fees to win recruiting — Ascend offers '~45% reduction in fixed fees' and caps Broker Fees at $3,000/agent. That directly trades revenue-per-agent for agent count. If these programs succeed at recruiting, the recurring high-margin fee base RMAX depends on gets diluted; if they fail, agent count keeps bleeding. Either way the near-term revenue trajectory is capped.